Recent high-throughput genomic analyses have converged on mutational hotspots in human HCC confirming telomerase expression, β-catenin signaling, TP53 related signaling, and chromatin modifications among the core deregulated pathways in HCC initiation and/or progression [47,48,49,50] (Figure 3). This evidence concerns the gene TP53 and hepatocellular carcinoma.